Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees
Oct 17 (Reuters) - IPCA Laboratories Ltd IPCA.NS: IPCA LABS - TO SELL DRUG INTERMEDIATES AND APIS UNIT IN ANKLESHWAR IPCA LABS - SALE CONSIDERATION SET AT 221.5 MILLION RUPEES IPCA LABS - SALE WILL NOT IMPACT COMPANY'S BUSINESS AND FINANCIALS Source text: ID:nBSE3qRXvC Further company coverage: IPCA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees